Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
about
Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study MethodologiesThe effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape ProvinceKS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy SamplesDOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youthComparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort StudyHas universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis.Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial.Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study.Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.Time to Drug-Resistant Tuberculosis Treatment in a Prospective South African Cohort.Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas
P2860
Q26767271-3A8DB2F1-8FF1-49DD-B7D4-68B4C81F5145Q29247880-D8B32326-1C3C-41E2-93D7-411FB9E65673Q33446895-997C6616-7C51-4491-A4DA-F9C5CB140AB0Q33704314-3454E979-C7AF-48BA-B015-330F43A1C9AFQ33867908-B5777FC5-23AA-4DDB-B880-F3BE911F45D7Q35941022-A4EAC50A-56FE-410B-9707-1144B24554EEQ36092906-BA6083BB-9282-4E47-B757-0232CC0390D0Q36136013-A70CEE4E-C695-4B60-BBA6-E7E79A071EE5Q36159840-A569A909-4CCE-4A89-906F-967B642D601FQ36182135-A4BA32C8-A7B4-4BE8-8F5D-39383AEE6C7BQ36281279-CE8ED8AC-0CC9-4261-B5AB-5F02934C8AFEQ36286134-F397E38B-C98E-4584-82D0-1AC78D9C3FC7Q36893640-C2BA89B9-F591-47B4-B3CE-50E80EEF1761Q37127612-E7519A52-5F60-46B1-AEF4-07A1B1CDF483Q38688148-710FAA0C-C79F-4A76-A64E-8D1E8EC16E37Q39070206-DF9DE45B-8207-4AB6-8E1C-6384D4BF220DQ39172214-CBFBE6B4-2297-4987-ACC2-06BF63ABC3ADQ40107565-3FC64EAA-22C0-4556-AD91-5A026BFAA652Q40332311-5E425E5D-F0A9-49B3-916B-953B90E01C09Q42687193-2E60E041-7FF6-4F35-A439-9EDC936343DDQ46410213-FD5E5429-0AE9-4C18-8090-A42B7B2D69E9Q47157596-0E5B65D8-945E-4A0F-821C-6A9805BBFD3DQ50044320-FB3F62C6-E3AB-4B86-9CD3-A33F5B9D4BC4Q56669652-3B9456CD-5EA4-40B3-A33E-A247F3E4A568
P2860
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@ast
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@en
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@nl
type
label
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@ast
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@en
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@nl
prefLabel
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@ast
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@en
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@nl
P2093
P2860
P50
P3181
P356
P1476
Impact of Decentralized Care a ...... n in Khayelitsha, South Africa
@en
P2093
Helen S Cox
Johnny F Daniels
Odelia Muller
Sizulu Moyo
Virginia De Azevedo
Vivian Cox
P2860
P304
P3181
P356
10.1093/OFID/OFV014
P407
P577
2015-01-01T00:00:00Z